ÂÜÀòÂÒÂ×

Carl Langren is the Chief Financial Officer at NewLink Genetics. Carl has held this position since November 2011. Prior to that, they were the VP Finance at BioProtection Systems Corporation from February 2005 to November 2011. Carl has over 13 years of experience in the biotechnology field, including finance, federal contracting, information systems, compliance, and operations.

They work with Nicholas N. Vahanian - Cofounder, President, Eugene P. Kennedy - Chief Medical Officer, and Gabriela R. Rossi - Vice President, Biologics Development. Carl Langren reports to Charles J. Link Jr, Co-Founder, Chairman, CEO & Chief Scientific Officer.